Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 1/2013

01.02.2013 | Molecular Imaging (ZA Fayad, Section Editor)

MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements

verfasst von: Amy W. Pollak, Christopher M. Kramer

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Evaluation of peripheral arterial disease by cardiovascular magnetic resonance imaging continues to develop. Of the clinical diagnostics tests currently available, magnetic resonance angiography is well established as one of the preferred techniques for determining areas of arterial occlusive disease affecting the lower extremities. Despite this, there have been new developments in non-gadolinium based contrast-enhanced studies as well as testing done at higher field strength scanners. In the research arena, magnetic resonance spectroscopy, calf muscle perfusion imaging and atherosclerotic plaque evaluation all have made significant advancements over the last year. These techniques are gaining traction as surrogate endpoints in clinical trials of novel therapeutics aimed at alleviating symptoms in patients with peripheral arterial disease.
Literatur
1.
Zurück zum Zitat Rajagopalan S, Mihai G. Perspectives on optimizing trial design and endpoints in peripheral arterial disease: a case for imaging-based surrogates as endpoints of functional efficacy. Cardiol Clin. 2011;29(3):419–31.PubMedCrossRef Rajagopalan S, Mihai G. Perspectives on optimizing trial design and endpoints in peripheral arterial disease: a case for imaging-based surrogates as endpoints of functional efficacy. Cardiol Clin. 2011;29(3):419–31.PubMedCrossRef
2.
Zurück zum Zitat Kribben A, Witzke O, Hillen U, et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis and therapy. J Am Coll Cardiol. 2009;53:1621–8.PubMedCrossRef Kribben A, Witzke O, Hillen U, et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis and therapy. J Am Coll Cardiol. 2009;53:1621–8.PubMedCrossRef
3.
Zurück zum Zitat Nielsen YW, Thomsen HS. Contrast-enhanced peripheral MRA: technique and contrast agents. Acta Radiologica. 2012;53:769–77.PubMedCrossRef Nielsen YW, Thomsen HS. Contrast-enhanced peripheral MRA: technique and contrast agents. Acta Radiologica. 2012;53:769–77.PubMedCrossRef
4.
Zurück zum Zitat • Malcolm PN, Lewis M. Prospective studies show that magnetic resonance angiography has high sensitivity and specificity for clinically relevant arterial steno-occlusions in adults with peripheral arterial disease symptoms. Evid Based Med. 2011;16:90–1. This is a well written review of the prospective studies for MRA used in PAD affecting the lower extremities.PubMedCrossRef • Malcolm PN, Lewis M. Prospective studies show that magnetic resonance angiography has high sensitivity and specificity for clinically relevant arterial steno-occlusions in adults with peripheral arterial disease symptoms. Evid Based Med. 2011;16:90–1. This is a well written review of the prospective studies for MRA used in PAD affecting the lower extremities.PubMedCrossRef
5.
Zurück zum Zitat van den Bosch H, Westenberg J, Duijm L, et al. 3 T versus 1.5 T MR angiography in peripheral arterial occlusive disease: an equivalence trial in comparison with digital subtraction angiography. J Cardiovas Magn R. 2012;14:139.CrossRef van den Bosch H, Westenberg J, Duijm L, et al. 3 T versus 1.5 T MR angiography in peripheral arterial occlusive disease: an equivalence trial in comparison with digital subtraction angiography. J Cardiovas Magn R. 2012;14:139.CrossRef
6.
Zurück zum Zitat Plank C, Wolf F, Langenberger H, et al. Improved detection of in-stent restenosis by blood pool agent-enhanced, high-resolution, steady-state magnetic resonance angiography. Eur Radiol. 2011;21:2158–65.PubMedCrossRef Plank C, Wolf F, Langenberger H, et al. Improved detection of in-stent restenosis by blood pool agent-enhanced, high-resolution, steady-state magnetic resonance angiography. Eur Radiol. 2011;21:2158–65.PubMedCrossRef
7.
Zurück zum Zitat Li J, Zhao JG, Li MH. Lower limb vascular disease in diabetic patients: a study with calf compression contrast-enhanced magnetic resonance angiography at 3.0 Tesla. Acad Radiol. 2011;18(6):755–63.PubMedCrossRef Li J, Zhao JG, Li MH. Lower limb vascular disease in diabetic patients: a study with calf compression contrast-enhanced magnetic resonance angiography at 3.0 Tesla. Acad Radiol. 2011;18(6):755–63.PubMedCrossRef
8.
Zurück zum Zitat • Miyazaki M, Akahane M. Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging. 2012;35:1–19. Thorough review of the current non-contrast enhanced MRA techniques.PubMedCrossRef • Miyazaki M, Akahane M. Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging. 2012;35:1–19. Thorough review of the current non-contrast enhanced MRA techniques.PubMedCrossRef
9.
Zurück zum Zitat Wedeen VJ, Meuli RA, Edelman RR, et al. Projective imaging of pulsatile flow with magnetic resonance. Science. 1985;230:946–8.PubMedCrossRef Wedeen VJ, Meuli RA, Edelman RR, et al. Projective imaging of pulsatile flow with magnetic resonance. Science. 1985;230:946–8.PubMedCrossRef
10.
Zurück zum Zitat Mihai G, Chung YC, Merchant A, Simonetti OP, Rajagopalan S. T1-weighted – SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience. J Magn Reson Imaging. 2010;31:502–9.PubMedCrossRef Mihai G, Chung YC, Merchant A, Simonetti OP, Rajagopalan S. T1-weighted – SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience. J Magn Reson Imaging. 2010;31:502–9.PubMedCrossRef
11.
Zurück zum Zitat Edelman RR, Sheehan JJ, Dunkle E, et al. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med. 2010;63:951–8.PubMedCrossRef Edelman RR, Sheehan JJ, Dunkle E, et al. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med. 2010;63:951–8.PubMedCrossRef
12.
Zurück zum Zitat Offerman EJ, Koktzoglou I, Glielmi C, Sen A, Edelman RR. Prospective self-gated nonenhanced magnetic resonance angiography of the peripheral arteries. Magn Reson Med. 2012. doi:10.1002/mrm.24240. Offerman EJ, Koktzoglou I, Glielmi C, Sen A, Edelman RR. Prospective self-gated nonenhanced magnetic resonance angiography of the peripheral arteries. Magn Reson Med. 2012. doi:10.​1002/​mrm.​24240.
13.
Zurück zum Zitat • Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology. 2011;260:282–93. This is an important area of development for NC-MRA.PubMedCrossRef • Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology. 2011;260:282–93. This is an important area of development for NC-MRA.PubMedCrossRef
14.
Zurück zum Zitat Klasen J, Blondin D, Schmitt P, et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA. Clin Radiol. 2012;67:441–6.PubMedCrossRef Klasen J, Blondin D, Schmitt P, et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA. Clin Radiol. 2012;67:441–6.PubMedCrossRef
15.
Zurück zum Zitat Haneder S, Attenberger U, Riffel P, et al. Magnetic resonance angiography (MRA) of the calf station at 3.0-T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA. Euro Radiol. 2011;21:1452–61.CrossRef Haneder S, Attenberger U, Riffel P, et al. Magnetic resonance angiography (MRA) of the calf station at 3.0-T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA. Euro Radiol. 2011;21:1452–61.CrossRef
16.
Zurück zum Zitat Williams DM, Fencil L, Chenevert TL. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle. Radiology. 1990;175(2):381–5.PubMed Williams DM, Fencil L, Chenevert TL. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle. Radiology. 1990;175(2):381–5.PubMed
17.
Zurück zum Zitat Gorny O, Santner W, Fraedrich G, et al. The run-off resistance (ROR) assessed on MR angiograms may serve as a valid scoring system in patients with symptomatic peripheral arterial disease (PAD) and correlates with the ankle-brachial pressure index (ABI). Euro J Radiol. 2012;81(6):1155–7.CrossRef Gorny O, Santner W, Fraedrich G, et al. The run-off resistance (ROR) assessed on MR angiograms may serve as a valid scoring system in patients with symptomatic peripheral arterial disease (PAD) and correlates with the ankle-brachial pressure index (ABI). Euro J Radiol. 2012;81(6):1155–7.CrossRef
18.
Zurück zum Zitat Isbell DC, Epstein FH, Zhong X, et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first pass contrast-enhanced magnetic resonance imaging. J Mag Reson. 2007;25:1013–20.CrossRef Isbell DC, Epstein FH, Zhong X, et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first pass contrast-enhanced magnetic resonance imaging. J Mag Reson. 2007;25:1013–20.CrossRef
19.
Zurück zum Zitat Jiji RS, West AM, Epstein FH, et al. Reproducibility of contrast-enhanced calf muscle perfusion MRI measures in peripheral arterial disease. Circulation. 2011;124:A11374. Jiji RS, West AM, Epstein FH, et al. Reproducibility of contrast-enhanced calf muscle perfusion MRI measures in peripheral arterial disease. Circulation. 2011;124:A11374.
20.
Zurück zum Zitat Versluis B, Backes WH, van Eupen MGA, et al. Magnetic resonance imaging in peripheral arterial disease: reproducibility of the assessment of morphological and functional vascular status. Invest Radiol. 2011;46:11–24.PubMedCrossRef Versluis B, Backes WH, van Eupen MGA, et al. Magnetic resonance imaging in peripheral arterial disease: reproducibility of the assessment of morphological and functional vascular status. Invest Radiol. 2011;46:11–24.PubMedCrossRef
21.
Zurück zum Zitat Versluis B, Dremmen MHG, Nelemans PJ, et al. MRI of arterial flow reserve in patients with intermittent claudication: feasibility and initial experience. PLoS One. 2012;7:e31514.PubMedCrossRef Versluis B, Dremmen MHG, Nelemans PJ, et al. MRI of arterial flow reserve in patients with intermittent claudication: feasibility and initial experience. PLoS One. 2012;7:e31514.PubMedCrossRef
22.
Zurück zum Zitat Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed. 1994;7:75–82.PubMedCrossRef Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed. 1994;7:75–82.PubMedCrossRef
23.
Zurück zum Zitat Wu W-C, Mohler E, Ratcliffe SJ, et al. Skeletal muscle microvascular flow in progressive peripheral arterial disease: assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. J Am Coll Cardiol. 2009;53:2372–7.PubMedCrossRef Wu W-C, Mohler E, Ratcliffe SJ, et al. Skeletal muscle microvascular flow in progressive peripheral arterial disease: assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. J Am Coll Cardiol. 2009;53:2372–7.PubMedCrossRef
24.
Zurück zum Zitat West AM, Meyer CH, Epstein FH, et al. Arterial spin labeling MRI reproducibly measures peak-exercise calf muscle perfusion in healthy volunteers and patients with peripheral vascular disease. JACC Cardiovasc Imag. 2012; in press. West AM, Meyer CH, Epstein FH, et al. Arterial spin labeling MRI reproducibly measures peak-exercise calf muscle perfusion in healthy volunteers and patients with peripheral vascular disease. JACC Cardiovasc Imag. 2012; in press.
25.
Zurück zum Zitat Ledermann H, Schulte AC, Heidecker HG, et al. Blood oxygenation level dependent magnetic resonance imaging of the skeletal muscle in patients with peripheral arterial occlusive disease. Circulation. 2006;113:2929–35.PubMedCrossRef Ledermann H, Schulte AC, Heidecker HG, et al. Blood oxygenation level dependent magnetic resonance imaging of the skeletal muscle in patients with peripheral arterial occlusive disease. Circulation. 2006;113:2929–35.PubMedCrossRef
26.
Zurück zum Zitat Partovi S, Karimi S, Jacobi S, et al. Clinical implications of skeletal muscle blood-oxygen-level-dependent (BOLD) MRI. MAGMA. 2012;25(4):251–61.PubMedCrossRef Partovi S, Karimi S, Jacobi S, et al. Clinical implications of skeletal muscle blood-oxygen-level-dependent (BOLD) MRI. MAGMA. 2012;25(4):251–61.PubMedCrossRef
27.
Zurück zum Zitat Isbell DC, Berr SS, Toledano AY, et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol. 2006;47:2289–95.PubMedCrossRef Isbell DC, Berr SS, Toledano AY, et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol. 2006;47:2289–95.PubMedCrossRef
28.
Zurück zum Zitat West AM, Anderson JD, Epstein FH, et al. Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study. Vasc Med. 2012;17:3–9.PubMedCrossRef West AM, Anderson JD, Epstein FH, et al. Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study. Vasc Med. 2012;17:3–9.PubMedCrossRef
29.
Zurück zum Zitat West AM, Anderson JD, Epstein FH, et al. LDL lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol. 2011;58:1068–76.PubMedCrossRef West AM, Anderson JD, Epstein FH, et al. LDL lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol. 2011;58:1068–76.PubMedCrossRef
30.
Zurück zum Zitat Wu JS, Buettner C, Smithline H, Ngo LH, Greenman RL. Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle Nerve. 2011;43:76–81.PubMedCrossRef Wu JS, Buettner C, Smithline H, Ngo LH, Greenman RL. Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle Nerve. 2011;43:76–81.PubMedCrossRef
31.
Zurück zum Zitat Andreas M, Schmid A, Keilani M, et al. Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial. J Cardiovasc Magn Reson. 2011;13:32.PubMedCrossRef Andreas M, Schmid A, Keilani M, et al. Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial. J Cardiovasc Magn Reson. 2011;13:32.PubMedCrossRef
32.
Zurück zum Zitat Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes. 2011;60:1361–9.PubMedCrossRef Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes. 2011;60:1361–9.PubMedCrossRef
33.
Zurück zum Zitat • Balu N, Wang J, Dong L, et al. Current techniques for MR imaging of atherosclerosis. Top Magn Reson Imag. 2009;20(4):203–15. This is an excellent review of the current techniques for evaluation of atherosclerosis using CMR.CrossRef • Balu N, Wang J, Dong L, et al. Current techniques for MR imaging of atherosclerosis. Top Magn Reson Imag. 2009;20(4):203–15. This is an excellent review of the current techniques for evaluation of atherosclerosis using CMR.CrossRef
34.
Zurück zum Zitat Isbell DC, Meyer CH, Rogers WJ, et al. Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9:71–6.PubMedCrossRef Isbell DC, Meyer CH, Rogers WJ, et al. Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9:71–6.PubMedCrossRef
35.
Zurück zum Zitat West AM, Anderson JD, Meyer CH, et al. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis. 2011;218:156–62.PubMedCrossRef West AM, Anderson JD, Meyer CH, et al. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis. 2011;218:156–62.PubMedCrossRef
36.
Zurück zum Zitat McDermott MM, Liu K, Carroll TJ, et al. Superficial femoral artery plaque and functional performance in peripheral arterial disease: Walking and Leg Circulation Study (WALCS III). JACC: Cardiovasc Imag. 2011;4:730–9.CrossRef McDermott MM, Liu K, Carroll TJ, et al. Superficial femoral artery plaque and functional performance in peripheral arterial disease: Walking and Leg Circulation Study (WALCS III). JACC: Cardiovasc Imag. 2011;4:730–9.CrossRef
37.
Zurück zum Zitat Bourque JM, Schietinger BJ, Kennedy JL, et al. Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis. Am J Cardiol. 2012;110:50–6.PubMedCrossRef Bourque JM, Schietinger BJ, Kennedy JL, et al. Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis. Am J Cardiol. 2012;110:50–6.PubMedCrossRef
38.
Zurück zum Zitat Bianda N, Di Valentino M, Periat D, et al. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. Eur Heart J. 2012;33:230–7.PubMedCrossRef Bianda N, Di Valentino M, Periat D, et al. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. Eur Heart J. 2012;33:230–7.PubMedCrossRef
39.
Zurück zum Zitat Brown R, Karmonik C, Brunner G, et al. Simultaneous bilateral magnetic resonance imaging of the femoral arteries in peripheral arterial disease patients. J Magn Reson Imag. 2011;34:150–6.CrossRef Brown R, Karmonik C, Brunner G, et al. Simultaneous bilateral magnetic resonance imaging of the femoral arteries in peripheral arterial disease patients. J Magn Reson Imag. 2011;34:150–6.CrossRef
40.
Zurück zum Zitat Chiu B, Sun J, Wang J, et al. Fast plaque burden assessment of the femoral artery using 3D black blood MRI and automated segmentation. Med Phys. 2011;38:5370–84.PubMedCrossRef Chiu B, Sun J, Wang J, et al. Fast plaque burden assessment of the femoral artery using 3D black blood MRI and automated segmentation. Med Phys. 2011;38:5370–84.PubMedCrossRef
41.
Zurück zum Zitat Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–73.PubMedCrossRef Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–73.PubMedCrossRef
42.
Zurück zum Zitat Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscl Throm Vasc. 2005;25:234–9. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscl Throm Vasc. 2005;25:234–9.
43.
Zurück zum Zitat Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta. Circulation. 2000;101:2503–9.PubMedCrossRef Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta. Circulation. 2000;101:2503–9.PubMedCrossRef
44.
Zurück zum Zitat Li F, McDermott MM, Li D, et al. The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: a high-spatial-resolution, multi-contrast weighted CMR study. J Cardiovasc Magn Reson. 2010;12:37.PubMedCrossRef Li F, McDermott MM, Li D, et al. The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: a high-spatial-resolution, multi-contrast weighted CMR study. J Cardiovasc Magn Reson. 2010;12:37.PubMedCrossRef
45.
Zurück zum Zitat McAteer MA, Schneider JE, Ali ZA, et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscl Throm Vasc. 2008;28:77–83.CrossRef McAteer MA, Schneider JE, Ali ZA, et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscl Throm Vasc. 2008;28:77–83.CrossRef
46.
Zurück zum Zitat Mitsumori LM, Ricks JL, Rosenfeld ME, Schmiedl UP, Yuan C. Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease. Int J Cardiovasc Imag. 2004;20:561–7.CrossRef Mitsumori LM, Ricks JL, Rosenfeld ME, Schmiedl UP, Yuan C. Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease. Int J Cardiovasc Imag. 2004;20:561–7.CrossRef
47.
Zurück zum Zitat Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for mri of atherosclerotic plaques. J Am Chem Soc. 2004;126:16316–7.PubMedCrossRef Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for mri of atherosclerotic plaques. J Am Chem Soc. 2004;126:16316–7.PubMedCrossRef
48.
Zurück zum Zitat Myers KS, Rudd JHF, Hailman EP, et al. Correlation between arterial fdg uptake and biomarkers in peripheral artery disease. JACC: Cardiovasc Imag. 2012;5:38–45.CrossRef Myers KS, Rudd JHF, Hailman EP, et al. Correlation between arterial fdg uptake and biomarkers in peripheral artery disease. JACC: Cardiovasc Imag. 2012;5:38–45.CrossRef
Metadaten
Titel
MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements
verfasst von
Amy W. Pollak
Christopher M. Kramer
Publikationsdatum
01.02.2013
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 1/2013
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-012-9175-z

Weitere Artikel der Ausgabe 1/2013

Current Cardiovascular Imaging Reports 1/2013 Zur Ausgabe

Molecular Imaging (ZA Fayad, Section Editor)

Imaging Atherosclerotic Plaques with MRI: Role of Contrast Agents

Molecular Imaging (ZA Fayad, Section Editor)

Molecular MRI of Atherosclerosis with USPIO

Molecular Imaging (ZA Fayad, Section Editor)

Lipid-Based Nanoparticles in Cardiovascular Molecular Imaging

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.